Matches in Wikidata for { <http://www.wikidata.org/entity/Q91404057> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91404057 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91404057 description "scientific article published on 22 November 2019" @default.
- Q91404057 description "wetenschappelijk artikel" @default.
- Q91404057 description "наукова стаття, опублікована 22 листопада 2019" @default.
- Q91404057 name "Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?" @default.
- Q91404057 name "Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?" @default.
- Q91404057 type Item @default.
- Q91404057 label "Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?" @default.
- Q91404057 label "Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?" @default.
- Q91404057 prefLabel "Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?" @default.
- Q91404057 prefLabel "Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?" @default.
- Q91404057 P1433 Q91404057-781A52F3-3692-4E8A-9446-26B11B0668A5 @default.
- Q91404057 P1476 Q91404057-13106D61-238F-4EED-B8D4-E7827FAF23D9 @default.
- Q91404057 P2093 Q91404057-6010EC77-04C7-42D0-8B66-D1D0F98A9F1A @default.
- Q91404057 P2093 Q91404057-69F5615A-5E2D-4651-B6ED-6F14B6FDE47D @default.
- Q91404057 P2093 Q91404057-A0DE326F-50E3-4D44-A995-F8E1C16ACD38 @default.
- Q91404057 P304 Q91404057-20DDB6A2-3078-4325-9475-5F285C1D3E46 @default.
- Q91404057 P31 Q91404057-C8B24FD0-CA7C-4763-B45B-DFE7F9173598 @default.
- Q91404057 P356 Q91404057-7A34B2F0-4D35-44D5-AEE0-BD622537879B @default.
- Q91404057 P433 Q91404057-6358A299-E004-4227-A48E-93AC128B634D @default.
- Q91404057 P478 Q91404057-59AB430D-1E01-4358-9A84-03BCFF2D4895 @default.
- Q91404057 P50 Q91404057-B448ABC4-96BE-427D-B606-E203ED10BF5E @default.
- Q91404057 P50 Q91404057-E2A0D6AE-8428-4CC8-9A89-4B209D3683A8 @default.
- Q91404057 P577 Q91404057-5B4CD54F-2F7B-4541-AAF7-B63E986B36B6 @default.
- Q91404057 P698 Q91404057-BFABF55A-1A55-41D4-8200-AB08B4ABCA0B @default.
- Q91404057 P356 1078-0432.CCR-19-2337 @default.
- Q91404057 P698 31757876 @default.
- Q91404057 P1433 Q332253 @default.
- Q91404057 P1476 "Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?" @default.
- Q91404057 P2093 "Angelo Paci" @default.
- Q91404057 P2093 "Benjamin Besse" @default.
- Q91404057 P2093 "Nathalie Chaput" @default.
- Q91404057 P304 "787-792" @default.
- Q91404057 P31 Q13442814 @default.
- Q91404057 P356 "10.1158/1078-0432.CCR-19-2337" @default.
- Q91404057 P433 "4" @default.
- Q91404057 P478 "26" @default.
- Q91404057 P50 Q91404052 @default.
- Q91404057 P50 Q91404054 @default.
- Q91404057 P577 "2019-11-22T00:00:00Z" @default.
- Q91404057 P698 "31757876" @default.